Viking Therapeutics stock sinks after mixed results from its obesity pill trial, raising doubts over safety, tolerability and ...

We recently published 10 Big Names With Surprising Gains. Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of Wednesday’s best performers. Viking Therapeutics bounced back by 5.46 percent on Wednesday ...

Viking Therapeutics' stock drops 40% despite strong Phase 2 weight-loss drug results. See here to know why I remain ultra ...

When bad news drops, investors have a tendency to sell first and ask questions later. Let's take a closer look at why Viking ...

In the second quarter, attributable net income increased by 45 percent to 1.5 billion yuan from 1.067 billion yuan in the ...

In addition to Raymond James, Viking Therapeutics also received a Buy from William Blair’s Andy Hsieh in a report issued yesterday. However, on the same day, Citi maintained a Hold rating on Viking ...